HONG KONG — International experts convened by the World Health Organization (WHO) have reviewed the proposed first volume of an International Herbal Pharmacopoeia, a set of global quality standards for herbal medicines that aims to make traditional medicine products safer and more consistent across countries.
The meeting, hosted by Hong Kong’s Department of Health from 16 to 18 November, examined proposed quality specifications for 12 herbal medicines, along with general chapters and a chapter on biodiversity, traditional knowledge and the sustainable use of medicinal plants, according to the Hong Kong government. WHO said the meeting advanced its work on internationally harmonised quality standards.

What the experts reviewed
Experts from all six WHO regions — Africa, the Americas, the Eastern Mediterranean, Europe, South-East Asia and the Western Pacific — took part. India’s Pharmacopoeia Commission for Indian Medicine and Homoeopathy, part of the Ministry of Ayush, contributed technical expertise alongside Hong Kong’s Department of Health.
A pharmacopoeia is a collection of official standards describing how medicines and their ingredients should be identified, tested and stored. For herbal medicines, these standards set out how to confirm that the correct plant species and plant part are used, and how to test for purity, strength and contaminants such as heavy metals, pesticides and microbes.
The first volume of the International Herbal Pharmacopoeia is expected to contain monographs, or detailed quality specifications, for 12 herbal medicines. It will also include general chapters on testing methods and a chapter addressing biodiversity, traditional knowledge and the sustainable use of herbal medicines.
What officials said
Liu Jinfeng, Vice Minister of China’s National Health Commission and Commissioner of the National Administration of Traditional Chinese Medicine, addressed the meeting by video. He called for openness and collaboration and said: “In developing the IHP, we should uphold scientific and evidence-based approaches.”
Hong Kong’s Director of Health, Ronald Lam, described establishing evidence-based approaches for integrating traditional medicine into the global health system as a challenge shared by all countries. Kim Sungchol, head of the Traditional Medicine Norms, Standards and Systems Integration Unit at WHO’s Global Traditional Medicine Centre, delivered opening remarks.
Part of WHO’s traditional medicine strategy
Developing the pharmacopoeia falls under the second strategic objective of WHO’s Global Traditional Medicine Strategy 2025–2034, which focuses on strengthening the regulation of traditional, complementary and integrative medicine products, practices and practitioners.
WHO held its first expert meeting on the pharmacopoeia in Hong Kong in November 2024 and has met several times since, most recently in June 2026, also in Hong Kong. The project builds on the Hong Kong Chinese Materia Medica Standards, a programme launched in 2002 that has published 12 volumes covering standards for 357 Chinese medicinal materials.
Separately, WHO’s International Regulatory Cooperation for Herbal Medicines (WHO-IRCH), a network of regulators, held an online workshop in September on quality control, standardisation and sustainability, and will hold its 17th annual meeting on 16 and 17 December 2026.
WHO’s Global Traditional Medicine Centre, established in Jamnagar, India, in 2022 with support from the Indian government, leads much of the organisation’s work on evidence, data and standards for traditional medicine, working with WHO headquarters and regional offices.
Why quality standards matter
Herbal and traditional medicines are used in most countries. In WHO’s 2023 global survey, 170 of its 194 Member States reported that their populations use traditional medicine. For many people, particularly in parts of Africa and Asia, these products are an important part of everyday health care.
But quality varies widely. Problems reported in different countries include the wrong plant species being used, adulteration with undeclared pharmaceutical ingredients, contamination with heavy metals, pesticides or microbes, and inconsistent strength between batches. These issues can make products ineffective or harmful, and can cause serious liver and kidney damage in some cases.
Because herbal products are increasingly traded across borders, differing national standards create gaps that make it harder for regulators to check quality. Internationally harmonised standards are intended to give regulators, manufacturers and laboratories a common reference, helping to keep substandard and falsified products off the market.
What happens next
The experts’ comments will be used to refine the draft first volume before publication. WHO has not announced a publication date. Further monographs are expected in later volumes as the work expands to more herbal medicines used in different regions.
Hong Kong officials said the territory’s new Centre for Medical Products Regulation, due to be established this year, would support the city’s role in developing international standards for Chinese medicines.
Key facts at a glance
- WHO experts met in Hong Kong from 16 to 18 November 2026.
- They reviewed the first volume of an International Herbal Pharmacopoeia.
- The first volume covers quality specifications for 12 herbal medicines.
- It includes a chapter on biodiversity and sustainable use.
- Experts came from all six WHO regions.
- India’s Pharmacopoeia Commission for Indian Medicine and Homoeopathy contributed.
- The work is part of WHO’s Global Traditional Medicine Strategy 2025–2034.
- The first expert meeting was held in November 2024.
- 170 WHO Member States reported traditional medicine use in a 2023 survey.
- Harmonised standards aim to reduce contaminated and falsified products.
Herbal products and patient safety
Many people assume that because a product is natural, it is safe. In reality, plants contain active substances that can have strong effects on the body. Some herbs can damage the liver or kidneys, cause allergic reactions, or interact with prescription medicines, changing how well those medicines work.
Well-known examples of interactions include St John’s wort, which can reduce the effectiveness of some contraceptive pills, antidepressants, anti-HIV medicines and transplant medicines, and ginkgo, which may increase bleeding risk in people taking blood thinners. Products bought online or from unregulated sellers carry a higher risk of contamination or hidden ingredients.
Quality standards cannot guarantee that a herbal medicine works, which requires evidence from clinical studies. But they can help ensure that a product contains what its label says, at a consistent strength, without harmful contaminants.
How quality testing works
Testing a herbal product starts with confirming that the right plant has been used. Laboratories examine the plant material’s appearance under a microscope, use chemical fingerprinting techniques such as chromatography to compare it with reference samples, and increasingly use DNA-based methods to detect substitution with cheaper or look-alike species.
The next step is checking for contaminants. Standards usually set limits for heavy metals such as lead, arsenic, cadmium and mercury, for pesticide residues, for toxins produced by moulds, and for bacteria and fungi. Some standards also test for natural toxins found in certain plant families that can damage the liver.
Finally, standards may specify markers, chemical substances characteristic of the plant, that can be measured to check consistency between batches. Agreeing on these methods internationally is complex, because different traditions use different plant parts, preparation methods and combinations, and because laboratories in different countries have different equipment and resources.
By producing shared monographs, the WHO initiative aims to give regulators, including those with limited laboratory capacity, a trusted reference they can adopt or adapt rather than developing every standard from scratch.
Traditional knowledge and biodiversity
The decision to include a chapter on biodiversity and traditional knowledge reflects growing concern that rising demand for some medicinal plants is driving over-harvesting, threatening wild species and the livelihoods of communities that depend on them. Some plants used in traditional medicine are now listed as endangered.
Many communities, particularly Indigenous peoples, have developed knowledge about medicinal plants over generations. International agreements, including the Nagoya Protocol under the Convention on Biological Diversity, aim to ensure that communities share in the benefits when their knowledge or genetic resources are used commercially. WHO’s strategy calls for respecting this knowledge while applying scientific methods to assess safety, quality and effectiveness.
What this means for patients and families
People who use herbal medicines should tell their nurse, pharmacist or healthcare provider about every product they take, including teas, supplements and remedies bought abroad or online. This helps professionals check for interactions and side effects.
Buying products from reputable, licensed sources, checking that they are registered with the national regulator where possible, and reporting any suspected side effects can all reduce risks. Herbal medicines should not be used to replace treatment for serious conditions without discussing it with a health professional.
Parents should be especially cautious about giving herbal products to babies and young children, and pregnant or breastfeeding women should seek advice before using any herbal medicine, because safety data for these groups are often limited.
What it means for nurses
Nurses are often the professionals patients feel most comfortable telling about their use of herbal and traditional remedies. Asking about them routinely, without judgement, during medication reviews and admissions helps identify potential interactions and adverse effects.
Nurses can also report suspected adverse reactions to herbal products through national pharmacovigilance systems, which helps regulators detect contaminated or harmful products. In settings where traditional medicine is widely used, building respectful relationships with traditional practitioners can support safer care and earlier referral when patients need it.
Before surgery, nurses in pre-assessment clinics should ask specifically about herbal products, because some can affect bleeding, blood pressure, blood sugar or the effects of anaesthetic medicines. Patients may need advice to stop certain products in advance, following local protocols and guidance from the surgical or anaesthetic team.
Questions and answers
What is the International Herbal Pharmacopoeia?
A set of WHO-coordinated global quality standards for herbal medicines, now in development.
How many herbal medicines are in the first volume?
Twelve, according to the Hong Kong government.
Does this mean WHO endorses these herbal medicines?
No. Quality standards describe how to test identity and purity; they do not prove a medicine works.
When will it be published?
WHO has not announced a date. Experts are still refining the draft.
Are herbal medicines safe?
Some are, but they can cause side effects and interact with other medicines. Always tell your nurse or healthcare provider what you take.
Who is developing the standards?
Experts from all six WHO regions, coordinated by WHO, with technical support from Hong Kong’s Department of Health and India’s Pharmacopoeia Commission.
How we reported this story
Nursing Media Network reports health news for an international audience. This report is based on official statements, surveillance data and published research, which are linked in the sources below. Figures are given as they stood on the date of publication and may change as authorities release new data. Where officials or researchers are quoted, their words are taken from their published statements.
This article is for information and does not replace advice from a nurse or healthcare provider who knows your situation. If you have symptoms or questions about your own health, contact your local health service.
Finding reliable health information
Health information online varies widely in quality. Prefer sources such as the World Health Organization, national health ministries, public health agencies, university hospitals and registered professional bodies. Be cautious with social media posts, miracle cures and products sold with promises that sound too good to be true.
If you read something that worries you or contradicts the advice you have been given, write it down and discuss it with your nurse or healthcare provider. They can explain how it applies to your own situation and help you separate evidence from rumour.
Questions to ask your nurse or healthcare provider
- Could my herbal remedy interact with my medicines?
- Is this product registered with our regulator?
- Are there safer alternatives for my condition?
- Should I stop a herbal product before surgery?
- How do I report a side effect?
But aren’t herbal medicines natural and therefore harmless?
Not always. Herbs contain active substances, some products are contaminated, and some interact with prescription medicines. Global quality standards are meant to reduce these risks.
Your next step: At your next appointment, bring a list of every herbal product or supplement you take and ask your nurse or pharmacist to check it against your medicines.
Related: FDA program to share drug reviews · Diclofenac safety · Keto diet and liver fat trial
Sources: Hong Kong government press release; WHO newsroom; Devdiscourse; WHO: first IHP meeting (2024).



Leave a Reply